TarasoutchiF. Prosthesis-Patient Mismatch Following Aortic Valve Replacement: Finding Predictors for Prevention. Arq. Bras. Cardiol. 2020;114(1):23-4.
Tarasoutchi,Flávio. Prosthesis-Patient Mismatch Following Aortic Valve Replacement: Finding Predictors for Prevention. Arq. Bras. Cardiol., v. 114, n. 1, p. 23-24, Jan. 2020.
Tarasoutchi,F. (2020). Prosthesis-Patient Mismatch Following Aortic Valve Replacement: Finding Predictors for Prevention. Arq. Bras. Cardiol.,114(1), 23-24.
Tarasoutchi,Flávio. Prosthesis-Patient Mismatch Following Aortic Valve Replacement: Finding Predictors for Prevention. Arq. Bras. Cardiol. [online]. 2020, vol. 114, n. 1, [cited 2025-09-06], pp.23-24. Available from: <https://abccardiol.org/en/short-editorial/prosthesis-patient-mismatch-following-aortic-valve-replacement-finding-predictors-for-prevention/>. ISSN 0066-782X.
Figure 1
Dyslipidemia as a central element in atherosclerotic cardiovascular disease. ASCVD: atherosclerotic cardiovascular disease; LDL-C: low-density lipoprotein cholesterol. Limitations of statin-based therapy (non-exhaustive) include suboptimal LDL-C goal attainment, statin-associated adverse effects that may affect adherence, and potential drug interactions. Residual risk reflects the involvement of multiple underlying pathways.
